Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Annovis Bio, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +5 vs. Q2 2024
- Shares held
- 1.18M
- +295.4K (+33.4%) vs. Q2 2024
- Total value
- $9.50M
- +$4.41M (+86.7%) vs. Q2 2024
- New holders
- 12
- 11 more added
- Sold out
- 7
- 4 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 380,255 | $3.06M | 0.00% | +18,901+5.2% | Added |
| Citadel Advisors LLC | 102,692 | $827.7K | 0.00% | +102,692 | New |
| BlackRock, Inc. | 101,495 | $818.1K | 0.00% | +101,495 | New |
| Geode Capital Management, LLC | 99,114 | $799.0K | 0.00% | +22,881+30.0% | Added |
| Group One Trading, L.P. | 52,767 | $425.3K | 0.02% | +52,767 | New |
| Quest Partners LLC | 46,002 | $370.8K | 0.03% | +46,002 | New |
| Wescott Financial Advisory Group, LLC | 41,607 | $335.4K | 0.04% | 00.0% | Unchanged |
| State Street Corp | 36,035 | $290.4K | 0.00% | +6,900+23.7% | Added |
| Sterling Investment Advisors, Ltd. | 34,474 | $277.9K | 0.07% | +1,000+3.0% | Added |
| Susquehanna International Group, LLP | 31,520 | $254.1K | 0.00% | +31,520 | New |
| Merit Financial Group, LLC | 26,700 | $215.2K | 0.00% | +5,000+23.0% | Added |
| D. E. Shaw & Co., Inc. | 24,410 | $196.7K | 0.00% | +24,410 | New |
| Bridgeway Capital Management, LLC | 22,100 | $178.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 21,934 | $176.8K | 0.00% | +2,699+14.0% | Added |
| Jane Street Group, LLC | 20,206 | $162.9K | 0.00% | +10,083+99.6% | Added |
| Spears Abacus Advisors LLC | 20,000 | $161.2K | 0.00% | +5,000+33.3% | Added |
| Bank of New York Mellon Corp | 19,059 | $153.6K | 0.00% | 00.0% | Unchanged |
| Greenwich Wealth Management LLC | 16,475 | $133.0K | 0.01% | +1,400+9.3% | Added |
| Bank of Montreal | 13,500 | $109.3K | 0.00% | +13,500 | New |
| Lokken Investment Group LLC | 12,235 | $98.6K | 0.04% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 10,000 | $80.6K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,746 | $78.6K | 0.00% | +999+11.4% | Added |
| Bryn Mawr Trust Co | 9,393 | $75.7K | 0.00% | +9,393 | New |
| Simplex Trading, LLC | 8,605 | $69.0K | 0.00% | +8,605 | New |
| Bank of America Corp | 6,080 | $49.0K | 0.00% | +1,015+20.0% | Added |
| JPMorgan Chase & Co | 3,800 | $30.6K | 0.00% | +3,800 | New |
| Tower Research Capital LLC (TRC) | 3,087 | $24.9K | 0.00% | −3,771−55.0% | Reduced |
| UBS Group AG | 1,847 | $14.9K | 0.00% | −11,143−85.8% | Reduced |
| Morgan Stanley | 1,350 | $10.9K | 0.00% | −4,148−75.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,200 | $9.67K | 0.00% | −75−5.9% | Reduced |
| Bokf, NA | 555 | $4.45K | 0.00% | +555 | New |
| Rhumbline Advisers | 350 | $2.82K | 0.00% | +350 | New |
| Game Plan Financial Advisors, LLC | 200 | $1.61K | 0.00% | 00.0% | Unchanged |
| WR Wealth Planners, LLC | 150 | $1.21K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 83 | $669 | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Modera Wealth Management, LLC | 0 | $0 | 0.00% | −30,513−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,907−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −4,778−100.0% | Sold out |
| Opal Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |